Anemia is associated with increased major bleeding complications and early mortality in patients undergoing percutaneous coronary intervention: Implications for choices in antithrombotic therapy

被引：0
|
作者：
Voeltz, M [1 ]
Attubato, MJ [1 ]
Fait, F [1 ]
Lincoff, M [1 ]
Manoukian, SV [1 ]
机构：
[1] Emory Univ, Sch Med, Atlanta, GA 30322 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2005年 / 45卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：31A / 31A
页数：1
相关论文
共 50 条
  • [31] Prognosis and antithrombotic therapy of patients with atrial fibrillation after undergoing percutaneous coronary intervention)
    Tanabe, Y.
    Tejima, T.
    Kitamura, T.
    Hojo, R.
    Komiyama, K.
    Fukamizu, S.
    Sakurada, H.
    Kobayashi, Y.
    EUROPEAN HEART JOURNAL, 2013, 34 : 353 - 354
  • [32] Duration of triple antithrombotic therapy and outcomes among patients undergoing percutaneous coronary intervention
    Shah, Rahman
    Delgado, Glenda
    Finks, Shannon W.
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2017, 7 : S66 - S68
  • [33] Utilization of triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention
    Hye-Jeong Choi
    Yonghyuk Lee
    Susin Park
    Nam Kyung Je
    European Journal of Clinical Pharmacology, 2023, 79 : 541 - 551
  • [34] Duration of Triple Antithrombotic Therapy and Outcomes Among Patients Undergoing Percutaneous Coronary Intervention
    Koskinas, Konstantinos C.
    Raber, Lorenz
    Zanchin, Thomas
    Pilgrim, Thomas
    Stortecky, Stefan
    Hunziker, Lukas
    Blochlinger, Stefan
    Billinger, Michael
    Gartwyl, Fabienne
    Moro, Christina
    Moschovitis, Aris
    Juni, Peter
    Heg, Dik
    Windecker, Stephan
    JACC-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (14) : 1473 - 1483
  • [35] Antithrombotic Therapy for Patients with Nonvalvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Review
    Krasner, Andrew
    Halperin, Jonathan L.
    CURRENT CARDIOLOGY REPORTS, 2013, 15 (07)
  • [36] The impact of clinical trials of antithrombotic therapy in patients undergoing contemporary percutaneous coronary intervention
    Tsai, T
    Smith, DE
    Kline-Rogers, E
    D'Haem, C
    Karve, M
    Patel, K
    Moscucci, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 23A - 23A
  • [37] Antithrombotic Therapy for Patients with Nonvalvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Review
    Andrew Krasner
    Jonathan L. Halperin
    Current Cardiology Reports, 2013, 15
  • [38] The Optimal Antithrombotic Therapy for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention With Stenting
    Iwasaki, Yusuke
    Fukunami, Masatake
    Yamada, Takahisa
    Okuyama, Yuji
    Morita, Takasi
    Sanada, Shoji
    Furukawa, Yoshio
    Masuda, Masaharu
    Yasui, Taku
    Ueda, Hiromichi
    Okada, Takeshi
    Kawasaki, Masato
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A429 - A429
  • [39] Triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention: a viewpoint
    Gwyn, Jennifer C. V.
    Thomas, Mark R.
    Kirchhof, Paulus
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2017, 3 (03) : 157 - 162
  • [40] The role of triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention
    Fanaroff, Alexander C.
    Lopes, Renato D.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2021, 69 : 11 - 17
12345